- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02155699
Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis
March 12, 2024 updated by: Vijay Mittal, University of Colorado, Boulder
Exercise and Markers of Medial Temporal Health in Youth at Ultra High-risk for Psychosis
The goal of this proposal is to test the feasibility and effectiveness of cardiovascular exercise in promoting brain health and improving related symptoms (e.g., hearing sounds that are not there, feeling emotionally detached from self and others), cognitive difficulties (troubles with memory and learning), and every day social-occupational functioning in youth at imminent risk for developing a psychotic disorder such as schizophrenia.
Understanding how exercise may protect or improve the health of a brain area that is implicated as a major contributing factor to the onset of psychosis may lead to a path-breaking new intervention that does not suffer from many of the side effects, costs, and other barriers that characterize treatments that are currently available for this group.
Because a significant portion of high-risk youth go on to develop a psychotic disorder in a short period, intervening at this stage may help to improve the clinical course and ultimately prevent the onset of a devastating and prevalent mental illness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Accumulating evidence from the animal literature, healthy populations, and schizophrenia studies suggests that regular exercise positively affects integral functions such as neurogenesis, synaptic plasticity and cognition.
Likewise, preliminary evidence suggests that aerobic activity has been associated with improved quality of life and a lower level of symptoms in patients with schizophrenia.
Because exercise has been found to stimulate human medial temporal neurogenesis, and related abnormalities have been widely observed in studies of schizophrenia, physical activity may be in an important intervention.
During the psychosis prodrome, a period immediately proceeding formal onset of psychotic disorders, adolescents experience subtle attenuated symptoms coupled with cognitive deterioration and a global decline in socio-occupational functioning and anywhere between 10-35% go on to transition to a psychotic disorder such as schizophrenia in a two-year period.
Despite the promise of exercise interventions, and the critical role medial temporal lobe abnormalities play in etiological models of psychosis, there have been no experimental studies of aerobic exercise in ultra-high risk youth (UHR).
Understanding the potential benefits of aerobic exercise in UHR youth is integral as the prodrome is a viable period of intervention in which considerable brain development is still occurring.
Further, as there have been challenges associated with many of the available interventions, and an increasing level of potential found in neuroplasticity-based interventions, understanding the effect of exercise on respective brain-behavior holds considerable promise.
Experimental research is sorely needed to determine if prescribed aerobic exercise can stimulate medial-temporal neurogenesis and ameliorate cognition and symptoms/functioning in this vital group.
In the proposed study, an expert team of experienced prodromal and exercise investigators will follow a group of 15 UHR adolescent and young adults (ages 16-24) through a 12 week exercise trial to determine which level of exercise intensity/frequency is tolerable for participants and optimal for improving aerobic fitness (65% of VO2max and 2 sessions per week versus 85% intensity and 3 sessions per peek) and if improvements in aerobic fitness (i.e., VO2max, VO2peak, ventilatory threshold) are associated with increases in medial temporal structure volume (hippocampus and parahippocampal gyrus) and accompanying improvements in cognitive function (i.e., including tasks known to recruit heavily on medial temporal structures) as well as symptomatology and social/role functioning.
If the benchmarks are met, this data will be used to streamline a three-year rater-blind controlled trial (15 UHR-exercise, 15 UHR waitlist-control) to determine the efficacy of the intervention in promoting medial temporal health as well as accompanying cognitive, clinical, and socio-occupational function improvement.
Participants will be followed up to 24-months to determine if the intervention has an affect on clinical course and transition to psychosis.
Taken together, this study is important for understanding the lessons necessary for planning a future large-scale trial, and has the potential to shed light on a promising new treatment for UHR youth.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Vijay A Mittal, Ph.D.
- Phone Number: (303) 492-3303
- Email: vijay.mittal@colorado.edu
Study Locations
-
-
Colorado
-
Boulder, Colorado, United States, 80309
- ADAPT Program
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 24 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- age 16-24
- no history of brain injury or neurological disease
- no contraindications to exercise training (as assessed by a Clinical Translational Research Center CTRC physician)
- no history or current treatment with antipsychotics
- no contraindications for being in an magnetic resonance imaging scanner.
- meet criteria for a prodromal syndrome based upon the Structure Interview for Prodromal Syndromes (SIPS) interview.
Exclusion Criteria:
- people who are extremely claustrophobic
- have a history of significant head injury
- other physical disorder that could affect brain functioning
- mental retardation
- history of substance use disorder within 6 months of screening interview
- have a psychotic disorder (at study entry) and/or have exhibited serious self-harm behaviors
- pregnant females
- people who have contraindications to magnetic resonance (MR) scanning including intracranial, intraorbital or intraspinal metal, pacemakers, cochlear implants or other non-MR-compatible devices
- inability of the subject or their parent/guardian to understand the informed consent document
- meeting criteria for an Axis I psychotic disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise 1
65% of V02 Max, 3x per week, 3 months
|
65% of VO2max and 2 sessions per week
|
Experimental: Exercise 2
85% of VO2 Max, 2x per week, 3 months
|
85% intensity and 3 sessions per peek
|
No Intervention: Waitlist
Waitlist (three months)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brain Volume
Time Frame: pre-trial, post-trial (3-months)
|
Medial temporal structures (hippocampus and parahippocampal gyrus) will be delineated automatically using the FMRIB's Integrated Registration and Segmentation Tool algorithm within the FMRIB's Software Library (FSL) image-processing suite.
Secondly, the structures will be evaluated with vertex analyses (assessing changes in shape post trial on a per-vertex basis), which will also be carried out utilizing FIRST.
Shape/appearance models used in FIRST are constructed from manually segmented images provided by the Center for Morphometric Analysis (CMA, Boston).
This approach is different from using a whole-structure summary measure like volume, as it allows visualization of the region of the shape that is changing as well as the type of shape change.
|
pre-trial, post-trial (3-months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Working Memory Assessment
Time Frame: pre-trial, post-trial (3-months)
|
Working Memory Assessment - Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery working memory subscale - a higher score indicates working memory better performance.
The Relational and Item-Specific Encoding task includes visual object representations of word stimuli.
Subjects make a two-button "yes/no" response to indicate whether items in each pair had been presented "together."To
prevent additional encoding of the relational object pairs the item recognition task precedes the associated recognition task.
Higher scores reflect the familiarity and recollection performance as well as hit rates and false alarm rates following encoding - better performance.
MATRICS Consensus Cognitive Battery working memory subscale using a t-score (0=population mean, standard deviation=10) and Relational and Item-Specific Encoding Task accuracy score in the RCT study using a task specific accuracy (d prime range; 0-100%).
|
pre-trial, post-trial (3-months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attenuated Psychosis Positive Symptom Subscales
Time Frame: pre-trial, post-trial (3-months)
|
The Structured Interview for Prodromal Symptoms (SIPS) will be administered to formally assess attenuated positive symptoms after inclusion in the study.
It will also be administered post-trial to track changes in clinical symptoms post intervention trial.
The SIPS rates the severity of relevant dimensions including positive symptoms along a 7-point scale ranging from absent (0) to severe and psychotic (6) across five symptom categories, resulting in a score that ranges from 0 (no positive symptoms) to 30 (psychosis along all symptoms dimensions).
|
pre-trial, post-trial (3-months)
|
Aerobic Fitness
Time Frame: pre-trial, post-trial (3 months)
|
VO2max was assessed via a modified Balke protocol by an exercise physiologist under the supervision of a physician.
In this modified Balke protocol, the treadmill speed was individualized in a procedure to elicit 70% of the age-predicted max heart rate and ratings of a "somewhat hard" perceived exertion (RPE).
Then, the speed of the treadmill remained the same throughout the test, but the incline of the treadmill belt increased 2% every 2 min (or 2.5% for speeds 6 mph or greater) to exhaustion.
Tests generally lasted 8-12 minutes to attain the recommended target for VO2max testing.
Measures indicate cardiovascular health with higher scores indicating greater health.
|
pre-trial, post-trial (3 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Vijay A Mittal, Ph.D., University of Colorado, Boulder
- Principal Investigator: Angela Bryan, Ph.D., University of Colorado, Boulder
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.
- Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703-15. doi: 10.1093/oxfordjournals.schbul.a007040. Erratum In: Schizophr Bull. 2004;30(2):following 217.
- Mittal VA, Gupta T, Orr JM, Pelletier-Baldelli A, Dean DJ, Lunsford-Avery JR, Smith AK, Robustelli BL, Leopold DR, Millman ZB. Physical activity level and medial temporal health in youth at ultra high-risk for psychosis. J Abnorm Psychol. 2013 Nov;122(4):1101-10. doi: 10.1037/a0034085.
- Niendam TA, Bearden CE, Zinberg J, Johnson JK, O'Brien M, Cannon TD. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull. 2007 May;33(3):772-81. doi: 10.1093/schbul/sbm020. Epub 2007 Apr 9.
- Ragland JD, Ranganath C, Barch DM, Gold JM, Haley B, MacDonald AW 3rd, Silverstein SM, Strauss ME, Yonelinas AP, Carter CS. Relational and Item-Specific Encoding (RISE): task development and psychometric characteristics. Schizophr Bull. 2012 Jan;38(1):114-24. doi: 10.1093/schbul/sbr146. Epub 2011 Nov 28.
- Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage. 2011 Jun 1;56(3):907-22. doi: 10.1016/j.neuroimage.2011.02.046. Epub 2011 Feb 23.
- Dean DJ, Bryan AD, Newberry R, Gupta T, Carol E, Mittal VA. A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study. J Clin Psychiatry. 2017 Nov-Dec;78(9):e1167-e1173. doi: 10.4088/JCP.16m11365.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2014
Primary Completion (Actual)
July 1, 2022
Study Completion (Actual)
July 1, 2022
Study Registration Dates
First Submitted
May 30, 2014
First Submitted That Met QC Criteria
June 2, 2014
First Posted (Estimated)
June 4, 2014
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CU 14-0200
- 4R33MH103231-03 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attenuated Psychosis Syndrome
-
Northwell HealthTerminatedAttenuated Psychosis SyndromeUnited States
-
Niuvanniemi HospitalKarolinska InstitutetWithdrawnAttenuated or Transient PsychosisFinland
-
University of UdineNational Research Council (CNR), Institute of Biomolecular Chemistry (ICB)...RecruitingClinical High Risk for Psychosis | Ultra High Risk for Psychosis | Attenuated Psychotic SymptomsItaly
-
Yale UniversityCompleted
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingClinical High Risk Syndrome of PsychosisChina
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of East AngliaNorfolk and Suffolk NHS Foundation TrustUnknownAt Risk Mental State | Attenuated Psychotic SymptomsUnited Kingdom
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingSeptic Shock | Artificial Intelligence | Intensive Care Unit Psychosis
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
Clinical Trials on Exercise 1
-
University Health Network, TorontoCompletedProstate CancerCanada
-
Instituto de Cardiologia do Rio Grande do SulRecruiting
-
Center for Health, Exercise and Sport Sciences,...CompletedSedentary LifestyleSerbia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
University of MichiganCompletedMetabolic Disease | Adipose TissueUnited States
-
Hacettepe UniversityCompleted
-
University of ReginaUniversity of Saskatchewan; Saskatchewan Health Research Foundation; First Steps...RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCanada
-
Arkansas Children's Hospital Research InstituteRecruiting
-
Institut de Recherches Cliniques de MontrealCompleted
-
University of ThessalyCompletedOverweight and ObesityGreece